Endovascular Engineering

Focus: Endovascular Engineering is a Series B-stage medical device company focused on thrombectomy systems for cardiovascular emergencies, headquartered in Menlo Park, CA. The company is developing minimally invasive solutions for acute thromboembolic diseases.

Cardiovascular

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

SERIES B

Open Jobs

About Endovascular Engineering

AI assessmentNot Hiring

No open roles listed right now. Follow Endovascular Engineering to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Hēlo PE Thombectomy System

Pulmonary Embolism

N/A

Clinical Trials (1)

NCT05597891Endovascular Engineering ENGULF Study

N/A

Help build intelligence for Endovascular Engineering

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Join a Series B company at the inflection point between development and commercialization with meaningful upside potential
Work on a novel thrombectomy platform (Hēlo PE) targeting pulmonary embolism, a high-mortality condition with significant unmet clinical need
Be part of a lean, early-stage team where individual impact on product development and regulatory strategy is substantial

Watch Out For

Company is pre-revenue with only 1 active clinical trial and no disclosed funding, creating uncertainty around runway and hiring capacity
Zero current open positions and no hiring-by-department data suggests the company may not be actively expanding, limiting near-term job opportunities
Founded in 2024 with minimal public information and no publications on record, making it difficult to assess scientific credibility or market traction

Generated by Claude from Endovascular Engineering's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2024

Portfolio: 1 clinical trial

Top TAs: Respiratory

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Respiratory

1 pipeline

Marketed

Pipeline